Relay Therapeutics Inc (RLAY)
Who owns Relay Therapeutics Inc (RLAY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 62.4% of the shares are freely tradable; institutional investors hold 87.0%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 12.80 | 27,904,963 | +0.0 | 03/31/2026 |
| COMMODORE CAPITAL LP | 7.80 | 17,000,000 | +0.0 | 03/31/2026 |
| Casdin Capital, LLC | 6.62 | 14,418,574 | +10.9 | 03/31/2026 |
| BlackRock Inc | 5.95 | 12,975,299 | -1.9 | 03/31/2026 |
| Perceptive Advisors LLC | 4.47 | 9,751,141 | +412.3 | 03/31/2026 |
| Vanguard Group Inc | 4.45 | 9,691,445 | +3.1 | 12/31/2025 |
| Bellevue Group AG | 3.58 | 7,795,242 | -6.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.39 | 7,387,465 | +0.0 | 03/31/2026 |
| State Street Corp | 2.86 | 6,233,545 | -3.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.64 | 5,757,111 | +0.3 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 28. Jul 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 1,459 | 18.61 | 27,152 |
| 28. Jul 2026 | Rahmer Peter | See remarks | Sell | 748 | 18.61 | 13,920 |
| 28. Jul 2026 | Bergstrom Donald A | President, R&D | Sell | 2,237 | 18.61 | 41,631 |
| 7. Jul 2026 | Patel Sanjiv | President and CEO | Sell | 48,199 | 19.58 | 943,736 |
| 6. Jul 2026 | Bergstrom Donald A | President, R&D | Sell | 8,660 | 18.71 | 162,029 |
| 6. Jul 2026 | Catinazzo Thomas | Chief Financial Officer | Sell | 17,717 | 18.69 | 331,131 |
| 30. Jun 2026 | Patel Sanjiv | President and CEO | Other | 3,056 | 6.95 | 21,239 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.